Company & Sponsor Intelligence
Washington University School of Medicine
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials25
Recruiting10
Completed8
Countries1
Therapeutic footprint
alzheimersdementia_otherdepressioneating_disordersepilepsymultiple_sclerosisother_neurologyparkinsonstraumatic_brain_injury
Indexed studies
NCT00768261Corticolimbic Degeneration and Treatment of Dementia
dementia_other · PHASE4
dementia_other · PHASE4
NCT01768832Exercise and Parkinson's: Comparing Interventions and Exploring Neural Mechanisms
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT02757521Nitrous TRD Bipolar Depression
depression · United StatesEARLY_PHASE1
depression · United StatesEARLY_PHASE1
NCT07758270Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
multiple_sclerosis · United StatesRECRUITING
multiple_sclerosis · United StatesRECRUITING
NCT03537547Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
depression · United StatesPHASE4
depression · United StatesPHASE4
NCT04518917Sing for Your Saunter - Dementia Supplement
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT06129838Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1
alzheimers · United StatesRECRUITING
alzheimers · United StatesRECRUITING
NCT00785304Advanced MRI in Blast-related TBI
traumatic_brain_injury · United StatesUNKNOWN
traumatic_brain_injury · United StatesUNKNOWN
NCT05269394Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
alzheimers · United StatesPHASE2, PHASE3
alzheimers · United StatesPHASE2, PHASE3
NCT05552157A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
alzheimers · United StatesPHASE2, PHASE3
alzheimers · United StatesPHASE2, PHASE3
NCT03181282Physical Therapy and Deep Brain Stimulation in Parkinson Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT01162382Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging Study
depression · United StatesNA
depression · United StatesNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →